Businessinsider.co.za | US experts concerned over AstraZeneca's 'outdated' data in vaccine trial results
AstraZeneca should urgently ensure the most accurate, up-to-date vaccine efficacy data was made public, an authority said.
Full Article
Businessinsider.co.za | US experts concerned over AstraZeneca's 'outdated' data in vaccine trial results
News24
0 shares
2 views
- More about:
AstraZeneca
You might like
Related news coverage
Shots in little arms: COVID-19 vaccine testing turns to kids
SeattlePI.com
The 9-year-old twins didn’t flinch as each received test doses of Pfizer’s COVID-19 vaccine -- and then a sparkly bandage to..
-
AstraZeneca COVID-19 vaccine trial data results in revised efficacy rate
Motley Fool
-
After US rebuke, AstraZeneca releases new vaccine data
IndiaTimes
-
NA Proactive news snapshot: Altiplano Metals, Deep-South Resources, Vuzix, Phunware, Co-Diagnostics, Duos Technologies UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Alternus Energy Group, Bragg Gaming Group, Cloud Nine Web3 Technologie, Cardiol Therapeutics UPDATE …
Proactive Investors
Advertisement
More coverage
Doctor on new AstraZeneca vaccine data, media coverage of pandemic
CBS News
After U.S. health officials called out AstraZeneca for using "outdated information" in its vaccine trial results, the drugmaker has..
-
AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated
Business Insider
-
AstraZeneca Covid-19 vaccine 76% effective in updated US trial results
IndiaTimes
-
AstraZeneca may have provided "outdated" coronavirus vaccine data, safety board claims
NaturalNews.com
-
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
Upworthy